IRIS UniCatt

Caira, Morena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.227
EU - Europa 3.654
AS - Asia 2.212
SA - Sud America 353
Continente sconosciuto - Info sul continente non disponibili 60
AF - Africa 49
OC - Oceania 7
Totale 10.562
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.144
DE - Germania 1.926
SG - Singapore 1.053
CN - Cina 634
SE - Svezia 362
UA - Ucraina 330
BR - Brasile 275
FR - Francia 216
IT - Italia 192
PL - Polonia 155
GB - Regno Unito 147
VN - Vietnam 135
IE - Irlanda 111
IN - India 76
FI - Finlandia 69
ID - Indonesia 69
RU - Federazione Russa 66
TR - Turchia 49
MX - Messico 36
JP - Giappone 35
AR - Argentina 34
IQ - Iraq 32
CA - Canada 26
BD - Bangladesh 25
HK - Hong Kong 24
ZA - Sudafrica 16
NL - Olanda 15
SA - Arabia Saudita 13
ES - Italia 12
BE - Belgio 11
VE - Venezuela 11
CO - Colombia 9
EC - Ecuador 9
PK - Pakistan 9
UZ - Uzbekistan 9
CL - Cile 8
KE - Kenya 8
IR - Iran 6
KZ - Kazakistan 6
AU - Australia 5
CI - Costa d'Avorio 5
IL - Israele 5
AL - Albania 4
AT - Austria 4
EG - Egitto 4
HU - Ungheria 4
JO - Giordania 4
LT - Lituania 4
MA - Marocco 4
TN - Tunisia 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
BO - Bolivia 3
CH - Svizzera 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
KR - Corea 3
MD - Moldavia 3
MY - Malesia 3
NG - Nigeria 3
PH - Filippine 3
RO - Romania 3
AZ - Azerbaigian 2
BB - Barbados 2
BN - Brunei Darussalam 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
DZ - Algeria 2
EU - Europa 2
GR - Grecia 2
GT - Guatemala 2
JM - Giamaica 2
KG - Kirghizistan 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
SV - El Salvador 2
TH - Thailandia 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BY - Bielorussia 1
CG - Congo 1
DM - Dominica 1
HN - Honduras 1
IS - Islanda 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
ME - Montenegro 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PY - Paraguay 1
Totale 10.501
Salva come PNG Salva come JPEG
Città #
Singapore 539
Ashburn 480
Chandler 474
San Jose 289
Jacksonville 196
Warsaw 148
San Mateo 145
Nürnberg 120
Dublin 110
Ann Arbor 102
Beijing 95
Dearborn 94
Nanjing 91
Woodbridge 77
New York 76
Wilmington 73
Jakarta 65
Bremen 63
Lauterbourg 61
Lawrence 56
Los Angeles 54
Boston 53
Houston 52
Hefei 50
Munich 47
Hanoi 45
Milan 44
Moscow 42
Nanchang 40
Zhengzhou 39
Ho Chi Minh City 38
Izmir 34
Seattle 33
Atlanta 32
Fairfield 31
Frankfurt am Main 31
Buffalo 30
Marseille 30
Tokyo 28
São Paulo 27
Lancaster 26
Kunming 24
Hong Kong 23
University Park 22
Shanghai 21
Hebei 20
Tianjin 20
Shenyang 19
Redwood City 18
Memphis 17
Mountain View 17
Boardman 16
Santa Clara 16
Chicago 15
Dallas 15
Jiaxing 15
Kent 15
Changsha 14
Cuauhtémoc 14
Philadelphia 14
Rome 14
Baghdad 12
Leawood 12
Brussels 11
Orem 11
Phoenix 11
Cambridge 10
Guangzhou 10
Hangzhou 10
Mexico City 10
Pune 10
Fremont 9
Porto Alegre 9
Rio de Janeiro 9
San Francisco 9
Auburn Hills 8
Nuremberg 8
St Louis 8
Brooklyn 7
Costa Mesa 7
Düsseldorf 7
Kraków 7
Montreal 7
Nairobi 7
Norwalk 7
Princeton 7
Toronto 7
Amsterdam 6
Cattolica 6
Haiphong 6
Las Vegas 6
London 6
Paris 6
Riyadh 6
Tashkent 6
Abidjan 5
Augusta 5
Belo Horizonte 5
Brasília 5
Campinas 5
Totale 4.812
Salva come PNG Salva come JPEG
Nome #
Factors associated with mortality in bacteremic patients with haematologic malignancies 529
A prospective survey of febrile events in hematological malignancies 463
Incidence of acute myeloid leukemia after breast cancer 386
Factors associated with mortality in bacteremic patients with hematologic malignancies. 380
Posttransplant lymphoproliferative disorders after liver transplantation: analysis of early and late cases in a 255 patient series 354
Increased production of gliotoxin is related to the formation of biofilm byAspergillus fumigatus: an immunological approach 325
A prospective survey of febrile events in hematological malignancies 319
Hema e-Chart: Italian Registry for prospective analysis of epidemiology, management and outcome of febrile events in patients with hematological malignancies 313
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 233
Factors associated with mortality in bacteremic patients with hematologic malignancies. 220
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia. 215
Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay 215
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 199
The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. 198
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 184
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). 173
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 171
Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 169
. Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. 162
A prospective survey of febrile events in hematological malignancies 157
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 155
Advanced mast cell disease: an Italian Hematological Multicenter experience. 154
Derivation and validation of a scoring system to identify patients with bacteremia and hematological malignancies at higher risk for mortality 153
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registry 153
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 153
Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry 152
Derivation and Validation of a Scoring System to Identify Patients with Bacteremia and Hematological Malignancies at Higher Risk for Mortality 151
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 147
A patient with acute myeloid leukemia and a solid mass in the colon. 144
Granulocyte transfusions as adjunctive treatment of invasive fungal diseases in neutropenic patients 144
Scedosporiosis in patients with acute leukemia: a retrospective multicenter report 140
Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: an Italian multicentre prospective survey 139
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies 137
Uncommon yeast infections in hematological patients: from diagnosis to treatment 137
First case of breakthrough pneumonia due to Aspergillus nomius in a patient with acute myeloid leukemia 134
Invasive Aspergillosis in patients with acute leukemia: update on morbidity and mortality--SEIFEM-C Report. 133
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 133
The use and efficacy of empirical versus pre-emptive therapy in the management of fungal infections: the HEMA e-Chart Project 133
SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients 131
Caspofungin for the treatment of candidaemia in patients with haematological malignancies 130
. Pulmonary aspergillosis: lights and shadows 127
Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B? 126
Systemic antifungal treatment after posaconazole prophylaxis: results from the SEIFEM 2010-C survey 125
The role of Gemtuzumab Ozogamicin in the treatment of acute myeloid leukemia patients. 122
A prospective, multicentre survey on antifungal therapy in neutropenic paediatric haematology patients 122
Uncommon mold infections in hematological patients: epidemiology, diagnosis and treatment 118
The role of primary antifungal prophylaxis in patients with haematological malignancies 116
Current therapeutic approaches to fungal infections in immunocompromised hematological patients 114
Multidrug resistant Pseudomonas aeruginosa bloodstream infection in adult patients with hematologic malignancies 113
Efficacy of combined surgery and antifungal therapies for the management of invasive zygomycoses in patients with haematological malignancies 112
The role of neutrophils in the development and outcome of zygomycosis in haematological patients 108
Evaluation of the Practice of Antifungal Prophylaxis Use in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results From the SEIFEM 2010-B Registry 106
Genetic PTX3 Deficiency and Aspergillosis in Stem-Cell Transplantation 102
Invasive fungal infections in patients with acute myeloid leukcemia and in those submitted to allogenic hemopoietic stem cell transplant: Who is at highest risk?. 100
Etiology of Febrile Episodes in Patients With Acute Myeloid Leukemia: Results From the Hema e-Chart Registry 100
ZYGOMYCOSIS: Current approaches to management of patients with haematological malignancies. 98
Combined voriconazole plus caspofungin therapy for the treatment of probable Geotrichum pneumonia in a leukemia patient 84
Invasive aspergillosis in acute leukemias: old and new risk factors and epidemiological trends 79
Hema e-Chart Registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections 78
Italian Hema e-Chart Group.Continuous surveillance of invasive fungal infection: a realistic goal for the near future. 76
Uncommon yeast infections in hematological patients: from diagnosis to treatment 75
The management of febrile neutropenia in the posaconazole era: a new challenge? 74
Risks for infection in patients with myelodysplasia and acute leukemia 69
Totale 10.562
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.397
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.397
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022489 0 60 7 24 16 11 13 86 25 42 71 134
2022/20231.207 123 174 109 224 92 163 45 104 138 5 25 5
2023/2024439 32 155 6 8 14 70 33 8 4 9 62 38
2024/2025934 40 36 67 15 104 32 15 43 190 69 169 154
2025/20262.497 386 61 132 205 458 143 462 159 179 188 62 62
2026/2027986 107 879 0 0 0 0 0 0 0 0 0 0
Totale 10.562